The British journal of dermatology
-
Randomized Controlled Trial Multicenter Study
Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.
Psoriasis has a well-documented, markedly negative effect on patient quality of life. ⋯ Infliximab induction and maintenance regimens resulted in rapid, substantial, sustained and clinically meaningful improvement in both dermatology-specific and general quality of life indices in patients with psoriasis, with total clearance resulting in maximum improvement.